Article: Patent No. 7,569,575 Issued on Aug. 4, Assigned to Santaris Pharma for Locked Nucleic Acid Derivative Synthesis Strategy (Danish, British Inventors)

ALEXANDRIA, Va., Aug. 8 -- Mads Detlef Sorensen, Troels Koch and Signe M. Christensen, all from Kobenhavn, Denamark, Christoph Rosenbohm of Copenhagen, Denmark, Jesper Wengel of Odense, Denamrk, and Daniel Sejer Pedersen of Cambridge, Great Britain, have developed a strategy for the synthesis of locked nucleic acid derivatives. The inventors were issued U.S. Patent No. 7,569,575 on Aug. 4.

The patent has been assigned to Santaris Pharma A/S, Hoersholm, Denmark.

According to the abstract released by the U.S. Patent & Trademark Office: "The present invention relates to a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!